252 related articles for article (PubMed ID: 17568782)
1. Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients.
Raila J; Henze A; Spranger J; Möhlig M; Pfeiffer AF; Schweigert FJ
Kidney Int; 2007 Aug; 72(4):505-11. PubMed ID: 17568782
[TBL] [Abstract][Full Text] [Related]
2. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes.
Cabré A; Lázaro I; Girona J; Manzanares J; Marimón F; Plana N; Heras M; Masana L
J Intern Med; 2007 Oct; 262(4):496-503. PubMed ID: 17875187
[TBL] [Abstract][Full Text] [Related]
3. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.
Cho YM; Youn BS; Lee H; Lee N; Min SS; Kwak SH; Lee HK; Park KS
Diabetes Care; 2006 Nov; 29(11):2457-61. PubMed ID: 17065684
[TBL] [Abstract][Full Text] [Related]
4. Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes.
Akbay E; Muslu N; Nayir E; Ozhan O; Kiykim A
J Endocrinol Invest; 2010 Nov; 33(10):725-9. PubMed ID: 20436266
[TBL] [Abstract][Full Text] [Related]
5. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients.
Takebayashi K; Suetsugu M; Wakabayashi S; Aso Y; Inukai T
J Clin Endocrinol Metab; 2007 Jul; 92(7):2712-9. PubMed ID: 17440021
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients.
Chang YH; Lin KD; Wang CL; Hsieh MC; Hsiao PJ; Shin SJ
Diabetes Metab Res Rev; 2008; 24(8):629-34. PubMed ID: 18973209
[TBL] [Abstract][Full Text] [Related]
7. Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus.
Frey SK; Spranger J; Henze A; Pfeiffer AF; Schweigert FJ; Raila J
Metabolism; 2009 Oct; 58(10):1386-92. PubMed ID: 19501859
[TBL] [Abstract][Full Text] [Related]
8. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
Graham TE; Yang Q; Blüher M; Hammarstedt A; Ciaraldi TP; Henry RR; Wason CJ; Oberbach A; Jansson PA; Smith U; Kahn BB
N Engl J Med; 2006 Jun; 354(24):2552-63. PubMed ID: 16775236
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of type 2 and type 1 diabetes on plasma RBP4 levels: the significance of transthyretin.
Pullakhandam R; Palika R; Ghosh S; Reddy GB
IUBMB Life; 2012 Dec; 64(12):975-82. PubMed ID: 23129325
[TBL] [Abstract][Full Text] [Related]
10. ALTERED CIRCULATING LEVELS OF RETINOL BINDING PROTEIN 4 AND TRANSTHYRETIN IN RELATION TO INSULIN RESISTANCE, OBESITY, AND GLUCOSE INTOLERANCE IN ASIAN INDIANS.
Pandey GK; Balasubramanyam J; Balakumar M; Deepa M; Anjana RM; Abhijit S; Kaviya A; Velmurugan K; Miranda P; Balasubramanyam M; Mohan V; Gokulakrishnan K
Endocr Pract; 2015 Aug; 21(8):861-9. PubMed ID: 26121433
[TBL] [Abstract][Full Text] [Related]
11. Association of urinary RBP4 with insulin resistance, inflammation, and microalbuminuria.
Park SE; Lee NS; Park JW; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY; Youn BS
Eur J Endocrinol; 2014 Oct; 171(4):443-9. PubMed ID: 24994759
[TBL] [Abstract][Full Text] [Related]
12. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome.
Makino S; Fujiwara M; Suzukawa K; Handa H; Fujie T; Ohtaka Y; Komatsu Y; Aoki Y; Maruyama H; Terada Y; Hashimoto K; Sugimoto T
Horm Metab Res; 2009 Mar; 41(3):221-6. PubMed ID: 19003725
[TBL] [Abstract][Full Text] [Related]
13. Association of retinol binding protein 4 and transthyretin with triglyceride levels and insulin resistance in rural thais with high type 2 diabetes risk.
Kwanbunjan K; Panprathip P; Phosat C; Chumpathat N; Wechjakwen N; Puduang S; Auyyuenyong R; Henkel I; Schweigert FJ
BMC Endocr Disord; 2018 May; 18(1):26. PubMed ID: 29747616
[TBL] [Abstract][Full Text] [Related]
14. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.
Klöting N; Graham TE; Berndt J; Kralisch S; Kovacs P; Wason CJ; Fasshauer M; Schön MR; Stumvoll M; Blüher M; Kahn BB
Cell Metab; 2007 Jul; 6(1):79-87. PubMed ID: 17618858
[TBL] [Abstract][Full Text] [Related]
15. Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus.
Basualdo CG; Wein EE; Basu TK
J Am Coll Nutr; 1997 Feb; 16(1):39-45. PubMed ID: 9013432
[TBL] [Abstract][Full Text] [Related]
16. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
[TBL] [Abstract][Full Text] [Related]
17. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Yang Q; Graham TE; Mody N; Preitner F; Peroni OD; Zabolotny JM; Kotani K; Quadro L; Kahn BB
Nature; 2005 Jul; 436(7049):356-62. PubMed ID: 16034410
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A in regulation of insulin responsiveness: mini review.
Noy N
Proc Nutr Soc; 2016 May; 75(2):212-5. PubMed ID: 26729422
[TBL] [Abstract][Full Text] [Related]
19. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice.
Mody N; Graham TE; Tsuji Y; Yang Q; Kahn BB
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E785-93. PubMed ID: 18285525
[TBL] [Abstract][Full Text] [Related]
20. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes.
Wolf G
Nutr Rev; 2007 May; 65(5):251-6. PubMed ID: 17566551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
